Search Results - "Clewell, Harvey"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals by Bois, Frédéric Y, Jamei, Masoud, Clewell, Harvey J

    Published in Toxicology (Amsterdam) (30-12-2010)
    “…Abstract Generic PBPK models, applicable to a large number of substances, coupled to parameter databases and QSAR modules, are now available for predictive…”
    Get full text
    Journal Article Conference Proceeding
  6. 6
  7. 7

    Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results by Yoon, Miyoung, Campbell, Jerry L., Andersen, Melvin E., Clewell, Harvey J.

    Published in Critical reviews in toxicology (01-09-2012)
    “…The field of toxicology is currently undergoing a global paradigm shift to use of in vitro approaches for assessing the risks of chemicals and drugs in a more…”
    Get full text
    Journal Article
  8. 8

    Temporal concordance between apical and transcriptional points of departure for chemical risk assessment by Thomas, Russell S, Wesselkamper, Scott C, Wang, Nina Ching Y, Zhao, Q Jay, Petersen, Dan D, Lambert, Jason C, Cote, Ila, Yang, Longlong, Healy, Eric, Black, Michael B, Clewell, 3rd, Harvey J, Allen, Bruce C, Andersen, Melvin E

    Published in Toxicological sciences (01-07-2013)
    “…The number of legacy chemicals without toxicity reference values combined with the rate of new chemical development is overwhelming the capacity of the…”
    Get full text
    Journal Article
  9. 9

    Dose-dependence of chemical carcinogenicity: Biological mechanisms for thresholds and implications for risk assessment by Clewell, Rebecca A., Thompson, Chad M., Clewell, Harvey J.

    Published in Chemico-biological interactions (01-03-2019)
    “…Current regulatory practices for chemical carcinogens were established when scientific understanding of the molecular mechanisms of chemical carcinogenesis was…”
    Get full text
    Journal Article
  10. 10

    Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures by Andersen, Melvin E., Mallick, Pankajini, Clewell, Harvey J., Yoon, Miyoung, Olsen, Geary W., Longnecker, Matthew P.

    Published in Environmental research (01-06-2021)
    “…Biomarkers of exposure can be measured at lower and lower levels due to advances in analytical chemistry. Using these sensitive methods, some epidemiology…”
    Get full text
    Journal Article
  11. 11

    A model of functional thyroid disease status over the lifetime by Dzierlenga, Michael W, Allen, Bruce C, Ward, Peyton L, Clewell, 3rd, Harvey J, Longnecker, Matthew P

    Published in PloS one (18-07-2019)
    “…Mathematical models of the natural history of disease can predict incidence rates based on prevalence data and support simulations of populations where thyroid…”
    Get full text
    Journal Article
  12. 12

    Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach by Tsuji, Joyce S., Chang, Ellen T., Gentry, P. Robinan, Clewell, Harvey J., Boffetta, Paolo, Cohen, Samuel M.

    Published in Critical reviews in toxicology (02-01-2019)
    “…The biologic effects of inorganic arsenic predominantly involve reaction of the trivalent forms with sulfhydryl groups in critical proteins in target cells,…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetic bias analysis of an association between clinical thyroid disease and two perfluoroalkyl substances by Dzierlenga, Michael W., Allen, Bruce C., Clewell, Harvey J., Longnecker, Matthew P.

    Published in Environment international (01-08-2020)
    “…•Bias was quantified in an association of clinical thyroid disease with PFAS.•A PBPK model was used to link thyroid disease, renal function and PFAS…”
    Get full text
    Journal Article
  14. 14

    Interspecies scaling of toxicity reference values in human health versus ecological risk assessments: A critical review by Clewell, Harvey J., Fuchsman, Phyllis C.

    “…Risk assessments that focus on anthropogenic chemicals in environmental media—whether considering human health or ecological effects—often rely on toxicity…”
    Get full text
    Journal Article
  15. 15

    High-throughput in-silico prediction of ionization equilibria for pharmacokinetic modeling by Strope, Cory L., Mansouri, Kamel, Clewell, Harvey J., Rabinowitz, James R., Stevens, Caroline, Wambaugh, John F.

    Published in The Science of the total environment (15-02-2018)
    “…•We have replaced a proprietary human variability model with an open-source EPA tool for high throughput risk prioritization.•Introduced the ionizable atom…”
    Get full text
    Journal Article
  16. 16

    Is the relationship between prenatal exposure to PCB-153 and decreased birth weight attributable to pharmacokinetics? by Verner, Marc-André, McDougall, Robin, Glynn, Anders, Andersen, Melvin E, Clewell, 3rd, Harvey J, Longnecker, Matthew P

    Published in Environmental health perspectives (01-10-2013)
    “…A recent meta-analysis based on data from > 7,000 pregnancies reported an association between prenatal polychlorinated biphenyl (PCB)-153 exposure and reduced…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A Method to Integrate Benchmark Dose Estimates with Genomic Data to Assess the Functional Effects of Chemical Exposure by Thomas, Russell S., Allen, Bruce C., Nong, Andy, Yang, Longlong, Bermudez, Edilberto, Clewell, Harvey J., Andersen, Melvin E.

    Published in Toxicological sciences (01-07-2007)
    “…The use of genomic technology for assessing health risks associated with chemical exposure has significant potential, but its direct application has proven to…”
    Get full text
    Journal Article
  19. 19
  20. 20